Organon & Co. (OGN)

USD 11.25

(5.79%)

Total Assets Summary of Organon & Co.

  • Organon & Co.'s latest annual total assets in 2023 was 12.05 Billion USD , up 10.07% from previous year.
  • Organon & Co.'s latest quarterly total assets in 2024 Q2 was 12.15 Billion USD , up 2.21% from previous quarter.
  • Organon & Co. reported annual total assets of 10.95 Billion USD in 2022, up 2.57% from previous year.
  • Organon & Co. reported annual total assets of 10.68 Billion USD in 2021, up 2.37% from previous year.
  • Organon & Co. reported quarterly total assets of 12.75 Million USD for 2024 Q3, up 4.92% from previous quarter.
  • Organon & Co. reported quarterly total assets of 12.15 Billion USD for 2024 Q2, up 2.21% from previous quarter.

Annual Total Assets Chart of Organon & Co. (2023 - 2018)

Historical Annual Total Assets of Organon & Co. (2023 - 2018)

Year Total Assets Total Assets Growth
2023 12.05 Billion USD 10.07%
2022 10.95 Billion USD 2.57%
2021 10.68 Billion USD 2.37%
2020 10.43 Billion USD -1.08%
2019 10.54 Billion USD 0.51%
2018 10.49 Billion USD 0.0%

Peer Total Assets Comparison of Organon & Co.

Name Total Assets Total Assets Difference
AbbVie Inc. 134.71 Billion USD 91.049%
Bristol-Myers Squibb Company 95.15 Billion USD 87.329%
Bristol-Myers Squibb Company Ce 95.15 Billion USD 87.329%
Johnson & Johnson 167.55 Billion USD 92.804%
Eli Lilly and Company 64 Billion USD 81.161%
Merck & Co., Inc. 106.67 Billion USD 88.697%
Novartis AG 99.94 Billion USD 87.935%
Pfizer Inc. 226.5 Billion USD 94.676%